The PURA gene mental retardation autosomal dominant type 31 genetic test is a specialized diagnostic procedure designed to identify mutations in the PURA gene, which have been associated with a rare form of intellectual disability known as mental retardation, autosomal dominant type 31. This condition is characterized by developmental delays, intellectual challenges, and in some cases, physical abnormalities and neurological issues. The test is crucial for early diagnosis, which can significantly aid in the management and treatment of the condition, potentially improving the quality of life for those affected.
Performed at DNA Labs UAE, a leading genetic testing facility, this test offers a comprehensive analysis of the PURA gene to detect any abnormalities that may indicate the presence of the disorder. The cost of the test is set at 4400 AED, reflecting the intricate technology and expertise required to conduct such a specialized genetic analysis. By choosing DNA Labs UAE for this test, patients and healthcare providers can expect high-quality services, accurate results, and the support needed to understand and manage the implications of the findings.
The "MBD5 Gene Mental Retardation Autosomal Dominant Type 1 Genetic Test" is a specialized diagnostic tool designed to identify mutations in the MBD5 gene, which are linked to mental retardation autosomal dominant type 1 (MRD1). This condition is characterized by various degrees of intellectual disability, potential developmental delays, and sometimes accompanying physical or neurological symptoms. The test is crucial for families seeking answers about developmental concerns, as it can confirm a diagnosis, inform clinical management, and aid in family planning.
Performed at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves analyzing the patient's DNA sample to look for specific genetic alterations in the MBD5 gene that are known to cause MRD1. The process is meticulous, ensuring high accuracy and reliability in the results.
The cost of the test is 4400 AED, reflecting the comprehensive nature of the analysis and the specialized expertise required to interpret the results. For families affected by or at risk of MRD1, this test offers invaluable insights into the genetic underpinnings of the condition, enabling informed decisions about care and support.
The EPB41L1 gene plays a crucial role in cognitive development and brain function. Mutations in this gene have been linked to Mental Retardation, Autosomal Dominant Type 11, a condition characterized by intellectual disabilities and possibly other neurological or physical abnormalities. To diagnose this condition, a genetic test targeting the EPB41L1 gene can be conducted.
At DNA Labs UAE, individuals suspected of having Autosomal Dominant Type 11 Mental Retardation can undergo a specialized genetic test to detect mutations in the EPB41L1 gene. This test is a crucial step in confirming the diagnosis, which can then guide appropriate management and intervention strategies for the affected individuals and their families.
The cost of the EPB41L1 gene test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis of the gene to identify any mutations that may be responsible for the condition. Given the importance of accurate diagnosis for effective treatment and support, this test represents a valuable tool for individuals and families seeking answers about developmental and cognitive concerns.
The EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the EFTUD2 gene, which are linked to the rare genetic disorder known as Mandibulofacial Dysostosis with Microcephaly (MFDM). This condition is characterized by distinctive craniofacial features, microcephaly, and often other physical and developmental abnormalities. The test is crucial for accurate diagnosis, guiding treatment options, and providing essential information for genetic counseling.
Performed through a detailed analysis of the patient's DNA, this test seeks to detect specific genetic alterations in the EFTUD2 gene that are responsible for the development of MFDM. Early diagnosis through genetic testing can significantly benefit affected individuals and their families by enabling timely intervention and support services.
The cost of the EFTUD2 Gene Mandibulofacial Dysostosis with Microcephaly Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive process of collecting a DNA sample, usually through a blood draw or cheek swab, conducting the genetic analysis, and providing a detailed report on the findings. The test is conducted with high precision and confidentiality, ensuring patients receive accurate and actionable results.
The PIEZO2 Gene Marden-Walker Syndrome Genetic Test is a specialized diagnostic tool designed to identify mutations in the PIEZO2 gene, which are associated with Marden-Walker Syndrome. Marden-Walker Syndrome is a rare congenital disorder characterized by multiple skeletal abnormalities, including a fixed facial expression, joint contractures, and a decrease in muscle tone. This condition is believed to be largely caused by mutations in the PIEZO2 gene, which plays a crucial role in the body's mechanical responses to stimuli.
The test is conducted at DNA Labs UAE, a reputable facility known for its comprehensive genetic testing services. The process involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the lab to detect any mutations in the PIEZO2 gene. This test is crucial for families seeking a definitive diagnosis of Marden-Walker Syndrome, as it can guide treatment options and help in understanding the prognosis.
The cost of the PIEZO2 Gene Marden-Walker Syndrome Genetic Test at DNA Labs UAE is 4400 AED. This price reflects the sophisticated technology and expertise required to accurately identify mutations in the PIEZO2 gene. While the cost may be significant, the test offers invaluable insights for affected individuals and their families, aiding in the management and understanding of Marden-Walker Syndrome.
The L1CAM gene plays a crucial role in the nervous system's development, particularly in the brain and spinal cord. Mutations in the L1CAM gene are associated with MASA syndrome, a rare genetic disorder that affects the development of the nervous system, leading to a range of symptoms including intellectual disability, aphasia, shuffling gait, and adducted thumbs. MASA is an acronym for the key features of the syndrome: Mental retardation, Aphasia, Shuffling gait, and Adducted thumbs.
To diagnose MASA syndrome, genetic testing of the L1CAM gene is essential. DNA Labs UAE offers a comprehensive genetic test for the L1CAM gene to identify mutations that could indicate MASA syndrome. This test is crucial for families seeking answers to developmental delays and neurological symptoms in their children, providing them with a clear diagnosis and the possibility of genetic counseling.
The cost of the L1CAM gene MASA syndrome genetic test at DNA Labs UAE is 4400 AED. This test is conducted with the utmost confidentiality and accuracy, using state-of-the-art technology to ensure reliable results. Families and individuals opting for this test at DNA Labs UAE can expect professional guidance throughout the testing process, from sample collection to the interpretation of results.
The XK Gene McLeod syndrome with or without chronic granulomatous disease Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify genetic mutations associated with McLeod syndrome, a rare condition that affects various systems in the body, including the nervous system, blood, and muscles. This syndrome can sometimes occur in conjunction with chronic granulomatous disease, an immune disorder that leads to recurrent infections and granuloma formation. The test specifically looks for abnormalities in the XK gene, which is crucial for the proper functioning of the Kx protein, involved in the development of these conditions. With a cost of 4400 AED, this genetic test is a critical tool for early diagnosis and management, helping healthcare providers to tailor appropriate treatment plans for affected individuals. By conducting this test at DNA Labs UAE, patients are ensured accurate, reliable results, leveraging state-of-the-art technology and expertise in genetic diagnostics.
The MLC1 Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts Genetic Test is a specialized diagnostic tool available at DNA Labs UAE. This test is designed to identify mutations in the MLC1 gene, which are linked to the development of Megalencephalic Leukoencephalopathy with Subcortical Cysts (MLC). MLC is a rare neurological disorder characterized by an enlarged brain (megalencephaly), abnormalities in the white matter of the brain (leukoencephalopathy), and the formation of fluid-filled cysts in certain areas of the brain. Early diagnosis through genetic testing is crucial for managing symptoms and improving the quality of life for affected individuals. The test is priced at 4400 AED and is conducted with precision and care at DNA Labs UAE, offering crucial insights for individuals and families affected by this condition.
The HEPACAM Gene Megalencephalic Leukoencephalopathy with Subcortical Cysts 2A (MLC2A) genetic test is a diagnostic examination performed to detect mutations in the HEPACAM gene, which are responsible for the development of MLC2A, a rare neurological disorder. This condition is characterized by an abnormal enlargement of the brain (megalencephaly) and the presence of cysts within the white matter of the brain, leading to a range of neurological symptoms including motor dysfunction, epilepsy, and cognitive delays.
DNA Labs UAE offers this specific genetic test at a cost of 4400 AED. The test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to identify any mutations in the HEPACAM gene. This genetic testing is crucial for the accurate diagnosis of MLC2A, enabling healthcare professionals to provide appropriate management and treatment plans for affected individuals. Moreover, it can also offer valuable information for family planning to those who have a history of MLC2A in their family.
The MT-TL1 gene is closely associated with MELAS syndrome, a mitochondrial disorder characterized by mitochondrial encephalomyopathy, lactic acidosis, and stroke-like episodes. Mutations in the MT-TL1 gene, which is responsible for mitochondrial tRNA leucine 1, can lead to impaired mitochondrial protein synthesis, affecting cellular energy production. This has significant implications for the nervous system and muscles, leading to the symptoms observed in MELAS syndrome.
To diagnose and understand the genetic basis of MELAS syndrome in affected individuals, genetic testing targeting the MT-TL1 gene mutations is crucial. DNA Labs UAE offers a specialized genetic test for identifying mutations in the MT-TL1 gene, which is essential for confirming the diagnosis of MELAS syndrome and related mitochondrial disorders. This test is particularly valuable for patients showing symptoms of MELAS syndrome or those with a family history of mitochondrial diseases.
The cost of the MT-TL1 gene-related genetic test at DNA Labs UAE is 4400 AED. This test provides critical insights into the genetic underpinnings of MELAS syndrome, enabling personalized treatment plans and genetic counseling for affected families. It involves collecting a DNA sample, usually through a blood draw or cheek swab, and analyzing it for specific mutations in the MT-TL1 gene that are known to cause the syndrome.
By offering this test, DNA Labs UAE plays a vital role in the diagnosis and management of MELAS syndrome, helping patients and their families navigate the complexities of this mitochondrial disorder with informed medical and genetic information.
